[Prospects for cancer immunotherapy using interleukin-1(IL-1) and interleukin-2(IL-2)].
D002999:Clone Cells; D006801:Humans; D007167:Immunotherapy; D007375:Interleukin-1 / Q000627:therapeutic use*; D007376:Interleukin-2 / Q000627:therapeutic use*; D007694:Killer Cells, Natural / Q000276:immunology; D008213:Lymphocyte Activation; D009369:Neoplasms / Q000628:therapy*
D007375:Interleukin-1; D007376:Interleukin-2